Skip to main content
logo
Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.150
-0.070 (-3.15%)
Sep 15, 2026, 12:18 PM EDT - Market open

Lipocine Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.571.9811.2-2.850.516.14
Revenue Growth
-62.70%-82.35%---96.90%-
Gross Profit
1.571.9811.2-2.850.516.14
Operating Income
-12.57-10.37-1.16-17.93-12.123.15
Net Income
-11.85-9.630.01-16.35-10.76-0.63
Earnings Per Share
-1.82-1.77-0.00-3.14-2.15-0.19
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
23.2714.9321.6322.0432.5346.64
Total Debt
0.260.45---2.31
Net Cash (Debt)
23.0114.4821.6322.0432.5344.33
Net Cash Growth
30.11%-33.06%-1.82%-32.26%-26.62%214.90%
Net Cash Per Share
3.522.663.994.186.198.60

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-11.19-9.76-1.22-11.87-11.97-4.41
Capital Expenditures
---0.09-0.01-0.13-0.01
Free Cash Flow
-11.19-9.76-1.31-11.88-12.1-4.42
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%-100.00%100.00%
Operating Margin
-800.82%-524.69%-10.32%--2423.88%19.49%
Pretax Margin
-755.11%-487.04%0.08%573.57%-2151.59%-3.93%
Profit Margin
-755.13%-487.05%0.07%--2151.73%-3.93%
FCF Margin
-713.03%-493.79%-11.71%--2420.53%-27.38%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--3124.75---
Forward PE
-7.757.757.757.757.75
PS Ratio
11.6622.552.33-5.2070.425.42